2025-11-14T11:42:52-06:00 2024-12-31 351178661 BLUE & CO LLC 12800 N MERIDIAN ST STE 400 CARMEL IN 46032 990 2024-01-01 463155025 ALLIANCE FOR SAFE ONLINE PHARMACIES ALLI 2023127438 1500 K ST NW SUITE 1100 WASHINGTON DC 20005 CARRIE HARNEY PRESIDENT 2023127438 2025-11-14 1 0 ANGELA N CRAWFORD CPA P00573197 3178488920 2025-11-10 2024 2025-03-06 01:10:19Z CARRIE HARNEY 1500 K ST NW SUITE 1100 WASHINGTON DC 20005 1130129 0 X HTTPS://BUYSAFERX.PHARMACY/ X 2013 DC PROMOTE GLOBAL POLICIES AND PROGRAMS FOR IMPROVED PATIENT SAFETY INVOLVING ONLINE DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. 11 11 0 11 0 0 572738 868129 276390 262000 0 0 0 0 849128 1130129 20013 0 0 0 0 0 0 0 0 1166916 537551 1186929 537551 -337801 592578 162271 598776 234891 78818 -72620 519958 X ASOP GLOBAL IS DEDICATED TO ADDRESSING THE GROWING PUBLIC HEALTH THREAT OF ILLEGAL ONLINE DRUG SELLERS THROUGH STRATEGIC EFFORTS AROUND THE GLOBE, CONCENTRATING ITS ACTIVITIES IN RESEARCH, EDUCATION, INTERNET COMMERCE COMPANY VOLUNTARY ACTIONS, AND POLICY AND ADVOCACY. 0 0 504147 262000 CONSUMER EDUCATION. ASOP CONTINUED TO INVEST RESOURCES TO BETTER DEVELOP THE AVAILABLE DATA AND RESEARCH RELATED TO CONSUMER AND HEALTHCARE PROVIDER BEHAVIOR AND UTILIZATION OF ONLINE PHARMACIES AND INTERNET-BASED HEALTHCARE SERVICES. RESULTS FROM STUDIES WERE CIRCULATED TO KEY POLICYMAKERS AND STAKEHOLDERS, AND USED TO ENGAGE WITH MEDIA, TO HIGHLIGHT THE LACK OF AWARENESS AND MISCONCEPTION AMERICAN CONSUMERS HAVE OF PURCHASING DRUGS ONLINE. THE SIGNIFICANT FINDINGS FROM THE SURVEY WERE INCLUDED IN 10 MEDIA PIECES AND EMPHASIZED IN OVER 30 INTERVIEWS IN WHICH ASOP PARTICIPATED. ASOP TRACKED THE DE-INDEXING OF DOMAIN NAMES ON SEARCH ENGINE PLATFORMS PURSUANT TO FDA WARNING LETTERS WITH CONCURRENT REVIEWS OF THE AVAILABILITY AND ACCESSIBILITY OF POTENTIALLY COUNTERFEIT OR SUBSTANDARD PRODUCTS VIA SOCIAL MEDIA PLATFORMS. THE FINDINGS WERE SHARED IN VARIOUS MEETINGS TO HELP KEY AGENCIES CONSIDER A SEARCH ENGINE APPROACH TO STRENGTHEN THEIR ABILITY TO TAKE ENFORCEMENT ACTION AGAINST WEBSITES MENTIONED IN WARNING LETTERS.LEGISLATIVE ADVOCACY OF LEGISLATION WHICH WOULD DECREASE ILLEGAL ONLINE DRUG SALES. ASOP ADVISED AND EDUCATED PARTNERS AND STAKEHOLDER ORGANIZATIONS (INCLUDING PATIENTS, CAREGIVERS, HEALTHCARE PROVIDERS, MEMBERS OF THE PHARMACEUTICAL SUPPLY AND DISTRIBUTION CHAIN, REGULATORS, AND POLICYMAKERS) OF THE RISKS ASSOCIATED WITH ILLEGAL ONLINE PHARMACIES AND THREATS ASSOCIATED WITH THE IMPORTATION OF PRESCRIPTION DRUGS FROM FOREIGN COUNTRIES. ASOP ISSUED 24 PRESS RELEASES AND STATEMENTS ON FEDERAL ACTIONS RELATED TO DRUG IMPORTATION, ACCESS TO WHOIS DATA, FAKE COVID-19 ONLINE SCAMS, AND MORE. ASOP JOINED TWO COALITIONS WITH SIMILAR POLICY PRIORITIES AND PARTICIPATED IN ADVANCING THE GROUPS' ALIGNED GOALS AND MISSION. BY ENGAGING IN ROUNDTABLE DISCUSSIONS WITH MULTI-DISCIPLINARY STAKEHOLDERS, ASOP HAD THE OPPORTUNITY TO RAISE THE EXISTING SUPPLY CHAIN THREATS AND CONSUMER HARMS TO BROADER AND DIVERSE AUDIENCES. EDUCATE GLOBAL HEALTH REGULATORS THROUGH A SERIES OF BRIEFINGS. ASOP ACTIVELY ENGAGED IN DOMESTIC AND INTERNATIONAL FORUMS TO EDUCATE STAKEHOLDERS AND REGULATORS ON SAFE ONLINE PHARMACY PRACTICES, COMPLIANCE WITH DOMESTIC AND INTERNATIONAL LAW AND PRACTICE STANDARDS, AND DEVELOPMENT OF ROBUST LEGAL AND REGULATORY SCHEMES AIMED AT ENSURING PUBLIC HEALTH AND PATIENT SAFETY. BEYOND CONTINUED ENGAGEMENT WITH DOMESTIC REGULATORS AND POLICYMAKERS, ASOP ENGAGED WITH KEY STAKEHOLDERS IN CANADA, THE EU, AND OTHER AREAS TO PROVIDE POLICY BRIEFINGS AND RELEVANT INFORMATION TO THESE PARTNERS. 504147 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 6 0 1 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 0 0 0 0 0 X THE ORGANIZATION 2023127438 1500 K ST NW SUITE 1100 WASHINGTON DC 20005 X CARRIE HARNEY PRESIDENT 1.00 X X 0 0 0 JOHN HERTIG SECRETARY 1.00 X X 0 0 0 JEFFREY GREN TREASURER 1.00 X X 0 0 0 ILISA BERNSTEIN DIRECTOR 1.00 X 0 0 0 DAN BURKE DIRECTOR 1.00 X 0 0 0 KEITH JACOBS DIRECTOR 1.00 X 0 0 0 ELIZABETH JUNGMAN DIRECTOR 1.00 X 0 0 0 LORI MAYALL DIRECTOR 1.00 X 0 0 0 MATTHEW STRAIT DIRECTOR 1.00 X 0 0 0 LEIGH VERBOIS DIRECTOR 1.00 X 0 0 0 RYAN WILLIAMS DIRECTOR 1.00 X 0 0 0 0 0 0 0 0 0 0 FAEGRE DRINKER BIDDLE & REATH LLP 1500 K STREET NW SUITE 1100 WASHINGTON DC 20005 CONSULTING 406179 1 868129 868129 MEMBERSHIP DUES 813410 262000 262000 262000 1130129 262000 0 0 X 34881 34881 4330 4330 436821 436821 6112 6112 2541 2541 160 160 24534 24534 PUBLIC RELATIONS 26173 26173 MISCELLANEOUS 1999 1999 537551 504147 33404 0 35271 469947 127000 128829 162271 598776 234891 78818 234891 78818 X -72620 519958 -72620 519958 162271 598776 592578 0 X 0 0 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 262000 60927 -114137 -53210 65500 -118710 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 PROGRAM SERVICES 27127 0 0 0 0 0 0 27127 0 27127 0 0 0 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTANT AND REVIEWED BY LEGAL COUNCIL PRIOR TO SENDING TO THE BOARD OR DIRECTORS BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C ASOP'S CONFLICT OF INTEREST POLICY REQUIRES ANNUAL FILING BY DIRECTORS AND OFFICERS OF A CONFLICT REPORT AND ACKNOWLEDGMENT AND TIMELY REPORTING OF NEW POTENTIAL CONFLICT SITUATIONS WHICH MAY ARISE. COUNSEL REVIEWS ANY POTENTIAL CONFLICT REPORTS AND PRESENTS SUCH SITUATION TO THE BOARD FOR DISCUSSION. THE BOARD REVIEWS IN-DEPTH SUCH REPORTS AND HAS TAKEN ACTION AS APPROPRIATE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS INCLUDING THE ARTICLES OF INCORPORATION AND BYLAWS, WHICH INCLUDE THE CONFLICT OF INTEREST POLICY, ARE MADE AVAILABLE TO MEMBERS OF THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G PROGRAMMATIC CONSULTING: PROGRAM SERVICE EXPENSES 436,821. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 436,821.